A cancer nanovaccine based on an FeAl-layered double hydroxide framework for reactive oxygen species-augmented metalloimmunotherapy

The complexity and heterogeneity of individual tumors have hindered the efficacy of existing therapeutic cancer vaccines, sparking intensive interest in the development of more effective in situ vaccines. Herein, we introduce a cancer nanovaccine for reactive oxygen species-augmented metalloimmunoth...

ver descrição completa

Detalhes bibliográficos
Principais autores: Chang, Mengyu, Wang, Man, Liu, Bin, Zhong, Wenbin, Jana, Deblin, Wang, Yifan, Dong, Shiyan, Antony, Abin, Li, Chunxia, Liu, Yuhui, Zhao, Zhongqi, Lin, Jun, Jiang, Wen, Zhao, Yanli
Outros Autores: School of Chemistry, Chemical Engineering and Biotechnology
Formato: Journal Article
Idioma:English
Publicado em: 2024
Assuntos:
Acesso em linha:https://hdl.handle.net/10356/177903